Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(17%)
Results Posted
100%(2 trials)

Phase Distribution

Ph phase_2
1
17%
Ph phase_3
2
33%
Ph not_applicable
3
50%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
2(33.3%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(2)
Other(3)

Detailed Status

unknown3
Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (16.7%)
Phase 32 (33.3%)
N/A3 (50.0%)

Trials by Status

unknown350%
recruiting117%
completed233%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_2

Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer

NCT05557604
completedphase_3

Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders

NCT04537078
unknownnot_applicable

Follicular Challenge Test to Predict Response to GnRH Agonist Triggering

NCT04973969
unknownnot_applicable

Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS

NCT02827656
completedphase_3

Comparative Study Between Minidose Long Protocol and Microdose Flare Protocol in Controlled Ovarian Hyperstimulation

NCT02342197
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05557604Phase 2

Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer

Recruiting
NCT04537078Phase 3

Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders

Completed
NCT04973969Not Applicable

Follicular Challenge Test to Predict Response to GnRH Agonist Triggering

Unknown
NCT02827656Not Applicable

Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS

Unknown
NCT02342197Phase 3

Comparative Study Between Minidose Long Protocol and Microdose Flare Protocol in Controlled Ovarian Hyperstimulation

Completed
NCT02144818Not Applicable

GnRH Agonist Triggering Supplemented With Hcg in Women With Poor Ovarian Response

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6